Global Uveal Melanoma Treatment Market: Market Outlook
Uveal is found in the back of the sclera and the cornea and has three parts: the iris, the ciliary body and the choroid. Uveal melanoma, including the iris choroid and cilira body, is referred to as cancer of the areas of the skin. This is the state in which the tumors emerge from the melanocytes that are responsible for the color of the eye inside the uva.
It is the most common form of intraocular malignancy in adults, although it is an uncommon disorder. The treatment of uveal melanoma depends on the size of the tumor, which is the most significant factor. In the early stages, this kind of melanoma is completely asymptomatic. Some modifications can be observed in tumor enlargement over time, such as pupil distortion, reduced visibility due to blurred vision, and secondary retinal detachment.
Fair hair, green or light, and blue colored eyes, and older age are risk variables for this form of cancer. The role of genetic mutations inherited in uveal melanoma is not yet understood. According to the American Cancer Society, the choroid produces about nine out of 10 eye melanomas. According to American Cancer Society, by the end of 2021 the eye cancer cases including new eye and orbit cancers (primarily melanomas) in the U.S. will reach to 3,320, out of which 1,750 in men and 1,570 in women.
What are the Key Trends Impacting Growth of the Uveal Melanoma Treatment Market?
The global market for uveal melanoma treatment is mainly driven by an increase in the incidence cases of eye cancer. One of the important reasons of the increase is said to be the rise in the use of electronic devices. This may be due to harmful UV radiation that directly affects the eyes of users of smartphones, tablets, desktops, laptops and other electronic devices. For intansce,
- According to the American Cancer Society, adults aged 60 years and above spend 5 or more hours per day using digital devices and prefer laptops & desktops for internet browsing.. Thus, this in turn is expected to increase the growth of uveal melanoma treatment market.
People with a weak immune system are vulnerable to the development of eye cancer. This is due to, greater risk of primary intraocular lymphoma, such as those with acquired immunodeficiency syndrome (AIDS), those on anti-rejection medications following organ transplantation, or the elderly. Often, infection with a bacterium called Chlamydophila psittaci increases the risk of uveal melanoma. The bacteria are caught from domestic animals including cats and birds that are infected. Besides, lung infections and conjunctival inflammation or conjunctivitis are caused by this bacteria. Governments of various countries, however, are taking major initiatives to provide better treatment at a minimal cost. Thus, this is in turn is supporting the growth of uveal melanoma treatment market.
How Discovery of Novel Biomarkers Fueling Demand for Uveal Melanoma Treatment?
Increased awareness and growing use of unique biomarkers including blood biomarkers in the diagnosis and treatment of uveal melanoma improves the detection accuracy and time spent on the process, which in turn fuels the revenue opportunities of uveal melanoma market.. Besides, technological developments in the field of biotechnology have improved the identification of possible biomarkers of uveal melanoma.
Some of the new biomarkers adopted for the diagnosis and progression of uveal melanoma include genetic, histological, radiographic and physiological diagnoses, which are expected to fuel the growth of Uveal melanoma treatment market.
Know More Details About the Report
What are The Key Challenges That May Restrain Growth of the Uveal Melanoma Treatment Market?
There are different factors hindering the growth of uveal melanoma treatment markets, such as the need for adequate skills and experience to conduct uveal melanoma treatment surgeries to provide high-quality and effective treatment services for uveal melanoma.
However, it is expected that a lack of awareness about early signs of eye cancer will deter the development of the global uveal melanoma market. In the early stages of treatment, which are critical for the patient, this causes delay. In addition, costly treatment for eye cancer is pulling down the development of the industry because it cannot be afforded by patients in underprivileged and underdeveloped areas of the world, which is anticipated to increase the growth of uveal melanoma treatment market.
Key players such as
- Eli Lilly & Co.
- Spectrum Pharmaceuticals Inc.
- Novartis AG
- Astra Zeneca plc
- Pfizer Inc.
- Others are actively involved in offering surgery products for uveal melanoma treatment.
What Strategies Are the Key Players Adopting for Increasing Their Market Share in The Uveal Melanoma Treatment Market?
Many companies in the market for uveal melanoma treatment are working to broaden their range of products. The most important approach to raising the customer pool, however, is through the marketing of the product through online portals. It is also expected that making the product available on online platforms would boost uveal melanoma treatment market growth.
In addition, merger & acquisition in the market for uveal melanoma care has evolved rapidly over the past few years to increase & improve geographic footprint and achieve operational skills. In the treatment market for uveal melanoma, industry mergers & acquisitions have witnessed steady growth across both expected and profitable customers.
- Immunocore Limited and Eli Lilly and Company announced on June 29, 2015 that they have entered into an immunotherapy-based clinical trial partnership to examine the usefulness for the treatment of melanoma of Immunocore's lead T cell receptor-based research therapeutic, IMCgp100, in combination with Lilly's galunisertib (LY2157299) and merestinib (LY2801653).
- The partnership aims to identify combination regimens in patients with metastatic cutaneous and uveal melanomas that include synergies in efficacy and durability.
Avail customized purchase options for your needs
What Are the Key Opportunities for Uveal Melanoma Treatment Manufacturers?
The development of an efficient screening tool for uveal melanoma will play a significant role in early detection and subsequent mortality reduction. Over the past few decades, recognition and screening for uveal melanoma has improved, leading to the early detection of uveal melanoma. The ultimate aim of reducing the rate of late-stage illness and mortality has not been achieved, however.
This is primarily due to inadequate screening techniques, which also yield false-positive and false-negative findings. To meet these criteria, groundbreaking companion diagnostic tests will lead to rapid acceptance among doctors and patient populations. Growing demand for safe non-invasive screening methods is therefore expected to fuel the growth of uveal melanoma treatment market in near future.
Why Is the U.S. A Big Market for Uveal Melanoma Treatment?
One of major reasons is the availability of advanced healthcare services and facilities, that promotes early detection of uveal melanoma and multiple palliative therapies. Due to which, U.S., holds the largest market share of uveal melanoma treatment market. Along with that, the growth of the uveal melanoma treatment market is expected to increase due to awareness of clinical trials to get a closer look at new procedures and treatment, and to increase government funding for global disease eradication. Hence, is expected to boost the demand for uveal melanoma treatment in near future.
Will Increasing Geriatric Population Results in Elevation of Uveal Melanoma Treatment Market in India?
Ageing is one of the main factor that is impacting the eyecare industry worldwide. Population aged 65+ years are growing day by day and with this growth the demand for need for the eye care related solutions increases. This increase in population and need represents the market opportunities for new consumer in India.
The India market is expected to grow at a lucrative rate owing to the constant rise in the incidence of eye cancer coupled with increased demand for cost-efficient therapeutics. Besides, owing to the presence of a large number of clinical research organizations, several pharmaceutical firms are drawn to this region for the production of effective and cheaper threapy. Thus, this in turn is expected to boost the demand for uveal melanoma Treatment.
According to WHO, by 2050, low-middle income countries will comprise of almost 80% of all older people.
- According to the UN Economic and Social Affairs Report (2019), the population of people aged over 65 years in Asia is expected to increase from 395.3 million in 2019 to 587.4 million by 2030, which will consequently drive the prevalence of age-related eye diseases in the region. The prevalence of glaucoma in adults over 45 years of age in China is about 3.5 percent; however, it rises dramatically with age and in the population over 65 years of age it is estimated to be about 9 percent.
- People with uveal melanoma are at risk of blindness or significant vision loss if left untreated. Most of the vision loss or related problems are preventable or treatable through simple measures.
An Adaptive Approach to Modern-day Research Needs
HOW COVID-19 Impact On The Growth of Uveal Melanoma Treatment Market?
The industry has been greatly impacted by the COVID-19 pandemic. There were initially high concerns, particularly for uveal melanoma treatment surgeons; because the virus lives in the back of the nose, there were high chances of transmission. Surgeons interact through telemedicine with their patients. There are only emergency surgeries, with stringent steps to be taken.
A breakthrough at this moment can restrain the revenue of uveal melanoma treatment products manufacturers thereby hampering uveal melanoma treatment market.
The research report on uveal melanoma treatment market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on uveal melanoma treatment market provides analysis and information according to market segments such as geographies, diagnostic tests, therapy type, location type, eye exam, end user and industry.
The Report Covers Exhaust Analysis On Uveal Melanoma Treatment market:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Report On Uveal Melanoma Treatment Market Includes Regional Analysis:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, U.K, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report on uveal melanoma treatment market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Have a report related query? Speak to us directly
Report on Uveal Melanoma Treatment Market Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
Key Segments of Uveal Melanoma Treatment Market Covered in the Report
Based on diagnostic tests, uveal melanoma treatment market has been segmented as
- High Resolution Ultrasound Biomicroscopy
- Fluorescein Angiography
- Oclular Coherence Tomography
- Indocyanine Green Angiography
Based on therapy type, uveal melanoma treatment market has been segmented as
- Surgical Resection Techniques (Transretinal Endoresection and Trans-Scleral Partial Choroidectomy)
- Transpupillary Thermotherapy
- Radiation Therapies
- External Beam Proton Therapy
- Gamma Knife Stereotactic Surgery
Based on Location Type, uveal melanoma treatment market has been segmented as
- Ciliary Melanoma
- Iris Melanoma
- Choroid Melanoma
Based on Eye exams, uveal melanoma treatment market has been segmented as
- Slit-Lamp Biomicrocopy
Based on end user, uveal melanoma treatment market has been segmented as
- Ambulatory Surgical Centers
- Ophthalmology Clinics
Based on the region, uveal melanoma treatment market has been segmented as
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.